Vanguard Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $3.74B | Buy |
|
|||||
|
2021
Q1 | $2.99B | Buy |
|
|||||
|
2020
Q4 | $3.03B | Sell |
|
|||||
|
2020
Q3 | $2.27B | Buy |
|
|||||
|
2020
Q2 | $1.91B | Sell |
|
|||||
|
2020
Q1 | $1.54B | Buy |
|
|||||
|
2019
Q4 | $1.81B | Sell |
|
|||||
|
2019
Q3 | $1.65B | Buy |
|
|||||
|
2019
Q2 | $2.18B | Buy |
|
|||||
|
2019
Q1 | $2.22B | Buy |
|
|||||
|
2018
Q4 | $1.58B | Buy |
|
|||||
|
2018
Q3 | $2.2B | Buy |
|
|||||
|
2018
Q2 | $1.94B | Buy |
|
|||||
|
2018
Q1 | $1.71B | Buy |
|
|||||
|
2017
Q4 | $1.82B | Buy |
|
|||||
|
2017
Q3 | $2.11B | Buy |
|
|||||
|
2017
Q2 | $1.8B | Buy |
|
|||||
|
2017
Q1 | $1.75B | Buy |
|
|||||
|
2016
Q4 | $1.72B | Buy |
|
|||||
|
2016
Q3 | $1.68B | Buy |
|
|||||
|
2016
Q2 | $1.57B | Buy |
|
|||||
|
2016
Q1 | $1.85B | Buy |
|
|||||
|
2015
Q4 | $2.47B | Buy |
|
|||||
|
2015
Q3 | $1.99B | Sell |
|
|||||
|
2015
Q2 | $2.36B | Buy |
|
|||||
|
2015
Q1 | $1.95B | Buy |
|
|||||
|
2014
Q4 | $1.97B | Buy |
|
|||||
|
2014
Q3 | $1.7B | Buy |
|
|||||
|
2014
Q2 | $1.58B | Buy |
|
|||||
|
2014
Q1 | $1.51B | Buy |
|
|||||
|
2013
Q4 | $1.26B | Buy |
|
|||||
|
2013
Q3 | $1.08B | Buy |
|
|||||
|
2013
Q2 | $842M | Buy |
|